Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D001712:Biperiden / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000517:prevention & control; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010640:Phenothiazines; D010880:Piperidines / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D010640:Phenothiazines; D010880:Piperidines; D001712:Biperiden